as on October 18, 2025 at 1:29 am IST
Day's Low
Day's High
2.91%
Downside
3.12%
Upside
52 Week's Low
52 Week's High
59.25%
Downside
116.22%
Upside
Check Pulmatrix Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$16.9M
EPS (TTM)
0Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-8.0M
Revenue (TTM)
369.0K
Profit Margin
0.00%
Return On Equity TTM
1405600.00%
Compare market cap, revenue, PE, and other key metrics of Pulmatrix Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $16.9M | -79.78% | NA | 0.00% | |
BUY | $63.1B | 231.27% | -505.15 | -12.96% | |
NA | $36.7B | NA | NA | -3.89% | |
BUY | $104.8B | 91.13% | 29.04 | 31.86% | |
BUY | $60.3B | -3.62% | 14.35 | 31.37% |
The Pulmatrix Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Pulmatrix Inc investment value today
Current value as on today
₹2,42,913
Returns
₹1,42,913
(+142.91%)
Returns from Pulmatrix Inc Stock
₹1,38,119 (+138.12%)
Dollar Returns*
₹4,794 (+4.79%)
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Pulmatrix Inc. Average target price of $10
Get share price movements and forecasts by analysts on Pulmatrix Inc.
What analysts predicted
51.9%UPSIDE
Target Price
$10
Current Price
$4.81
Analyzed by
7 Analysts
Target
$10.00
Pulmatrix Inc target price $10, a slight upside of 51.9% compared to current price of $4.81. According to 7 analysts rating.
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, PULM has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
In the last 1 year, PULM stock has moved up by 138.2%
Profit Spike
Netprofit is up for the last 6 quarters, -5.81M → -877.0K (in $), with an average increase of 51.6% per quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 150.9% return, outperforming this stock by 108.5%
Revenue Fall
Revenue is down for the last 4 quarters, 5.88M → 3.0K (in $), with an average decrease of 83.1% per quarter
Organisation | Pulmatrix Inc |
Headquarters | 945 Concord Street, Framingham, MA, United States, 01701 |
Industry | Health Technology |
CEO | Mr. Peter Ludlum CMA, MBA |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Peter Ludlum CMA, MBA | Interim CEO & Interim CFO |
Dr. Alexander M. Klibanov Ph.D. | Founder |
Pulmatrix Inc share price today is $4.81 as on at the close of the market. Pulmatrix Inc share today touched a day high of $4.96 and a low of $4.67.
Pulmatrix Inc share touched a 52 week high of $10.4 on and a 52 week low of $1.96 on . Pulmatrix Inc stock price today i.e. is closed at $4.81,which is 53.75% down from its 52 week high and 145.41% up from its 52 week low.
Pulmatrix Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Pulmatrix Inc (PULM) shares with as little as ₹87.954 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Pulmatrix Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Pulmatrix Inc share’s latest price of $4.81 as on October 18, 2025 at 1:29 am IST, you will get 2.0790 shares of Pulmatrix Inc. Learn more about
fractional shares .
Pulmatrix Inc stock has given -79.78% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?